ViiV, Janssen two-drug tablet approved in EU for HIV

ViiV Healthcare Ltd. (Brentford, U.K.) and Janssen Pharmaceutical Co. said the European Commission approved Juluca dolutegravir/rilpivirine to treat HIV-1 infection.

Read the full 204 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE